Company Filing History:
Years Active: 2025
Title: Innovations by Victoria Wagner in Biopharmaceuticals
Introduction
Victoria Wagner is an accomplished inventor based in Simi Valley, CA (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the development of bispecific antibodies. Her innovative work has the potential to advance therapeutic options for various medical conditions.
Latest Patents
Victoria Wagner holds a patent for "Bispecific antibodies with cleavable C-terminal charge-paired tags." This invention is directed to a CH3-containing molecule that comprises a first polypeptide with a CH3 domain and a negatively charged domain, as well as a second polypeptide with a CH3 domain and a positively charged domain. The patent outlines methods for conjugating synthetic molecules to a multi-specific antigen binding molecule, showcasing her expertise in antibody engineering.
Career Highlights
Victoria is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. Her role at Amgen allows her to collaborate with other talented professionals in the field, further enhancing her contributions to biopharmaceutical research.
Collaborations
Some of her notable coworkers include John K Kawooya and Alex W Jacobitz. Their collaboration fosters a dynamic environment for innovation and development in biopharmaceuticals.
Conclusion
Victoria Wagner's work exemplifies the impact of innovative thinking in the biopharmaceutical industry. Her patent on bispecific antibodies highlights her commitment to advancing medical science and improving patient outcomes.